🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will evaluate the immunogenicity, reactogenicity and safety of a...
Status
Completed
Location
Research Institute for Tropical Medicine
Start Date
2017-08-01
Trial ID
NCT03189745
Treatments Being Tested
The purpose of this study is to demonstrate, in 2-10 year old subjects, the...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-09-18
Trial ID
NCT00514904
This is a phase IV, single-center, observer-blind, randomized, controlled v...
Status
Completed
Location
Centre pour le Développement des Vaccins du Mali
Start Date
2020-12-23
Trial ID
NCT04450498
Treatments Being Tested
This study will investigate the long-term protection offered by GSK Biologi...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-02
Trial ID
NCT00390143
Treatments Being Tested
The purpose of this study is to evaluate the immunogenicity, safety and rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-03-24
Trial ID
NCT00196976
The purpose of this study is to evaluate the immunogenicity, safety and rea...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-07
Trial ID
NCT00126984
Treatments Being Tested
The purpose of this study is to evaluate that the vaccine produced with the...
Status
Completed
Location
GSK Investigational Site
Start Date
2005-06
Trial ID
NCT00227422
Treatments Being Tested
The purpose of this study is to demonstrate, in 18-55 year old adults, the ...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-04-09
Trial ID
NCT00453986
Treatments Being Tested
The purpose of this trial is to assess if the rate of febrile reactions fol...
Status
Completed
Location
GSK Investigational Site
Start Date
2007-07-02
Trial ID
NCT00496015
The purpose of this study is to assess the safety and reactogenicity of a b...
Status
Completed
Location
GSK Investigational Site
Start Date
2006-04-19
Trial ID
NCT00317109
Treatments Being Tested